UNSPSC 85893823: High dose rate (hdr) brachytherapy of testis using palladium 103 (pd-103)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of testis using palladium 103 (pd-103). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DV119BZ

UNSPSC 85893823, High dose rate (HDR) brachytherapy of testis using palladium 103 (Pd-103), is a Commodity code with no recent relevant state and local procurement activity. The single opportunity posted under this code—County of Santa Clara Health System solicitation RFSQHHSFY270052, due October 7, 2026—is for temporary health professional staffing services across ancillary clinical categories (audiology, cardiology, diagnostic imaging, gastroenterology, health services assistance, medical social work, ophthalmology, orthopedic services, patient transport, respiratory care, sterile processing, surgical/operating room, and therapy services), which bears no connection to the specialized oncology treatment the code nominally describes. This mismatch signals either a coding error in the source data or a miscategorization at the issuing body.

The absence of activity aligned with the code's actual scope—specialized brachytherapy equipment, supplies, or clinical delivery services—suggests minimal or no current state and local procurement volume for this narrow therapeutic modality. State and local health systems and hospital networks do not appear to be soliciting brachytherapy services, equipment, or staffing under this code at present. Firms considering this code should verify whether state procurement databases contain any corrected or properly categorized opportunities for HDR brachytherapy before committing resources to pursuit strategy.